TickerFactsScreenerDevelopers

IGC Pharma, Inc. (IGC) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2011: $285.4K2012: $5.5K2013: $326.1K2014: $8.5K2015: $76.5K2016: $122.2K2017: $145.7K2018: $136.0K2019: $15.0K2020: $4.39M2021: $1.47M2022: $236.0K2023: $310.0K2024: $138.0K2025: $112.0K$112.0K
2011Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$112.0K-18.8%
2024$138.0K-55.5%
2023$310.0K+31.4%
2022$236.0K-83.9%
2021$1.47M-66.5%
2020$4.39M+29160.0%
2019$15.0K-89.0%
2018$136.0K-6.6%
2017$145.7K+19.2%
2016$122.2K+59.7%
2015$76.5K+801.9%
2014$8.5K-97.4%
2013$326.1K+5850.3%
2012$5.5K-98.1%
2011$285.4K—